Literature DB >> 9784865

Biomimetic Diels-Alder cyclizations for the construction of the brevianamide, paraherquamide, sclerotamide, asperparaline and VM55599 ring systems.

R M Williams1, J F Sanz-Cervera, F Sancenón, J A Marco, K M Halligan.   

Abstract

A potentially bio-mimetic Diels-Alder cyclization to construct the bicyclo[2.2.2] ring system common to the paraherquamides, marcfortines, sclerotamides, brevianamides, VM55599, and asperparaline is reported. Epi-deoxybrevianamide E (22) is converted into the corresponding lactim ether (23) and then oxidized with DDQ to provide an azadiene (24) which is tautomerized in the presence of base to azadiene 25 which, spontaneously cyclizes to give a 2:1 mixture of cycloadducts 26 and 27. These cycloadducts are each in turn, converted into D,L-C-19-epi-brevianamide A (20) and D,L-brevianamide B (6). The stereochemical implications of the [4 + 2] cycloaddition is discussed in the context of a working hypothesis on the biosynthesis of this family, particularly VM55599.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784865     DOI: 10.1016/s0968-0896(98)00102-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  20 in total

1.  Studies Towards Paraherquamides E & F and Related C-labeled Putative Biosynthetic Intermediates: Stereocontrolled Synthesis of the α-Alkyl-β-Methylproline Ring System.

Authors:  Konrad Sommer; Robert M Williams
Journal:  Tetrahedron       Date:  2008-07-21       Impact factor: 2.457

2.  Studies on the Biosynthesis of the Stephacidin and Notoamide Natural Products: A Stereochemical and Genetic Conundrum.

Authors:  James D Sunderhaus; David H Sherman; Robert M Williams
Journal:  Isr J Chem       Date:  2011-04       Impact factor: 3.333

Review 3.  Natural products synthesis: enabling tools to penetrate Nature's secrets of biogenesis and biomechanism.

Authors:  Robert M Williams
Journal:  J Org Chem       Date:  2011-04-12       Impact factor: 4.354

4.  Total synthesis of brevianamide A.

Authors:  Robert C Godfrey; Nicholas J Green; Gary S Nichol; Andrew L Lawrence
Journal:  Nat Chem       Date:  2020-04-13       Impact factor: 24.427

Review 5.  Fungal origins of the bicyclo[2.2.2]diazaoctane ring system of prenylated indole alkaloids.

Authors:  Jennifer M Finefield; Jens C Frisvad; David H Sherman; Robert M Williams
Journal:  J Nat Prod       Date:  2012-04-15       Impact factor: 4.050

6.  Biosynthetic studies of the notoamides: isotopic synthesis of stephacidin A and incorporation into notoamide B and sclerotiamide.

Authors:  Jennifer M Finefield; Hikaru Kato; Thomas J Greshock; David H Sherman; Sachiko Tsukamoto; Robert M Williams
Journal:  Org Lett       Date:  2011-06-30       Impact factor: 6.005

7.  Calmodulin inhibitory activity of the malbrancheamides and various analogs.

Authors:  Kenneth A Miller; Mario Figueroa; Meriah W N Valente; Thomas J Greshock; Rachel Mata; Robert M Williams
Journal:  Bioorg Med Chem Lett       Date:  2008-10-17       Impact factor: 2.823

8.  Biomimetic total synthesis of malbrancheamide and malbrancheamide B.

Authors:  Kenneth A Miller; Timothy R Welch; Thomas J Greshock; Yousong Ding; David H Sherman; Robert M Williams
Journal:  J Org Chem       Date:  2008-03-18       Impact factor: 4.354

9.  An improved synthesis of alpha,beta-unsaturated nitrones relevant to the stephacidins and analogs thereof.

Authors:  Benjamin D Hafensteiner; María Escribano; Elena Petricci; Phil S Baran
Journal:  Bioorg Med Chem Lett       Date:  2009-04-18       Impact factor: 2.823

10.  Fungal-derived brevianamide assembly by a stereoselective semipinacolase.

Authors:  Ying Ye; Lei Du; Xingwang Zhang; Sean A Newmister; Morgan McCauley; Juan V Alegre-Requena; Wei Zhang; Shuai Mu; Atsushi Minami; Amy E Fraley; Maria L Adrover-Castellano; Nolan A Carney; Vikram V Shende; Feifei Qi; Hideaki Oikawa; Hikaru Kato; Sachiko Tsukamoto; Robert S Paton; Robert M Williams; David H Sherman; Shengying Li
Journal:  Nat Catal       Date:  2020-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.